Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Calderaro

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular CarcinomaJulien Calderaro, Léa Meunier, Cong Trung Nguyen, et al.
Nature Genetics|March 31, 2015
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targetsKornelius Schulze, Sandrine Imbeaud, Eric Letouzé, et al.
Journal of Oncology Practice|July 12, 2017
Renal Medullary Carcinoma: Establishing Standards in PracticeKathryn E Beckermann, Deva Sharma, Shruti Chaturvedi, et al.
Hepatology (Baltimore, Md.)|June 18, 2019
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular CarcinomaJean-Charles Nault, Yoann Martin, Stefano Caruso, et al.
The Lancet. Oncology|December 13, 2021
Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association studyEric Trépo, Stefano Caruso, Jie Yang, et al.
Gastroenterology|December 13, 2016
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant TransformationJean-Charles Nault, Gabrielle Couchy, Charles Balabaud, et al.
Annals of Hepatology|July 19, 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?Raffaele Brustia, Mohamed Bouattour, Manon Allaire, et al.
Surgery|November 19, 2023
Combined hepatocellular-cholangiocarcinoma compared to hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Different survival, similar recurrence: Report of a large study on repurposed databases with propensity score matchingBoris Amory, Claire Goumard, Alexis Laurent, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 14, 2023
ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinomaCharlotte Costentin, Etienne Audureau, Young Nyun Park, et al.
Hepatology (Baltimore, Md.)|April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)Pierre Nahon, Marianne Ziol, Long Pan, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular CarcinomaJulien Calderaro, Léa Meunier, Cong Trung Nguyen, et al.
Nature Genetics|March 31, 2015
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targetsKornelius Schulze, Sandrine Imbeaud, Eric Letouzé, et al.
Journal of Oncology Practice|July 12, 2017
Renal Medullary Carcinoma: Establishing Standards in PracticeKathryn E Beckermann, Deva Sharma, Shruti Chaturvedi, et al.
Hepatology (Baltimore, Md.)|June 18, 2019
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular CarcinomaJean-Charles Nault, Yoann Martin, Stefano Caruso, et al.
The Lancet. Oncology|December 13, 2021
Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association studyEric Trépo, Stefano Caruso, Jie Yang, et al.
Gastroenterology|December 13, 2016
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant TransformationJean-Charles Nault, Gabrielle Couchy, Charles Balabaud, et al.
Annals of Hepatology|July 19, 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?Raffaele Brustia, Mohamed Bouattour, Manon Allaire, et al.
Surgery|November 19, 2023
Combined hepatocellular-cholangiocarcinoma compared to hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Different survival, similar recurrence: Report of a large study on repurposed databases with propensity score matchingBoris Amory, Claire Goumard, Alexis Laurent, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 14, 2023
ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinomaCharlotte Costentin, Etienne Audureau, Young Nyun Park, et al.
Hepatology (Baltimore, Md.)|April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)Pierre Nahon, Marianne Ziol, Long Pan, et al.
Pageof 19